Clinical OMICS, a semi-monthly digital publication focusing on the application of OMICs technologies in clinical settings, releases its third issue today. It includes several special features:

  • Expect panomics, the integration of multiple omics readouts, to define the pathology report of the future.
  • Experts convened by the NIH propose guidelines for interpreting the pathogenicity of gene variants.
  • Next-generation sequencers are available that possess clinically relevant features such as ease of use, stability, turnaround time.

In addition, Clinical OMICS No. 3 announces a YouTube page and invites readers and clinical omics specialists to share their expertise.

The current issue’s regular sections also cover the 100K Project, an omics-centric approach to wellness; the widening availability of liquid biopsies, diagnostic tools that rely on circulating biomarkers; and the use of a global phosphorylation assay to guide drug selection for individual patients.

In addition, as always, Clinical OMICS includes news, new products, and a list of handy clinical apps.

Clinical OMICs is directed at clinical lab directors and managers, oncologists, infectious disease specialists, and cardiologists. Intended to serve as a resource for the development and standardization of best OMICs practices, Clinical OMICs provides critical information and insights on the trend toward personalized medicine.

This site uses Akismet to reduce spam. Learn how your comment data is processed.